Cisatracurium Besylate Injection, USP is a clear solution supplied as follows:
Cisatracurium Besylate Injection, USP, 2 mg cisatracurium per mL, is supplied in the following:
| Unit of Sale | Concentration |
|---|---|
NDC 0409-1098-02 | 10 mg/5 mL |
Carton containing 10 Single-dose Vials | (2 mg/mL) |
NDC 0409-1208-01 | 20 mg/10 mL |
Carton containing 10 Multiple-dose Vials | (2 mg/mL) |
NOTE: 10 mL Multiple-dose vials contain 0.9% w/v benzyl alcohol as a preservative [see Warnings and Precautions (5.2)].
Cisatracurium Besylate Injection, USP, 10 mg cisatracurium per mL is supplied in the following:
| Unit of Sale | Concentration |
|---|---|
NDC 0409-1103-01 | 200 mg/20 mL |
Carton containing 10 Single-dose Vials | (10 mg/mL) |
Intended only for use in the ICU.
Discard unused portion of the 5 mL and 20 mL single-dose vials.
Storage
Cisatracurium Besylate Injection, USP should be refrigerated at 2°C to 8°C (36°F to 46°F) in the carton to preserve potency. Protect from light. DO NOT FREEZE. Upon removal from refrigeration to room temperature storage conditions (25°C/77°F), use Cisatracurium Besylate Injection, USP within 21 days, even if re-refrigerated.
{{section_name_patient}}
{{section_body_html_patient}}
Additional Resources
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.
Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.
Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for a Pfizer medicine or a vaccine.
The submission will be reviewed during our standard business hours.
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.